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Edited by Sandro SonninoAbstract By comparing newly available cDNA sequences of the
human intermediate ﬁlament protein lamin B2 with published
sequences, we have identiﬁed an additional translation initiation
codon 60 nucleotides upstream of the previously assumed transla-
tion start. In addition, corresponding sequences were identiﬁed in
the chimpanzee, mouse, rat and bovine genes and cDNAs, respec-
tively. Therefore, we generated antibodies against these potential
20 new amino acids of the human sequence. By immunoblot anal-
ysis and immunoﬂuorescence microscopy we show that human
lamin B2 is indeed synthesized as a longer version than previously
reported, because it contains these additional 20 amino acids.
Notably, the sequence homology to mouse, rat and bovine lamin
B2 is signiﬁcantly lower in this segment than in that between
the second methionine codon and the start of the a-helical rod
indicating that the tip of the ‘‘head’’ is engaged in more species-
speciﬁc functions. Forced expression of the GFP-tagged authen-
tic ‘‘long’’ and the 20 amino acid shorter version of lamin B2 in
human cultured SW-13 cells demonstrated that both the longer
and the shorter version are properly integrated into the nuclear
lamina, although the shorter version exhibited a tendency to
disturb envelope architecture at higher expression levels.
 2006 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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envelope1. Introduction
Thenuclear envelope ofmetazoan cells is stabilized by amesh-
work of intermediate ﬁlaments (IFs) and a complex set of trans-
membrane proteins underlying the inner nuclearmembrane alsoAbbreviations: IF, intermediate ﬁlament; MALDI-TOF MS, matrix-
assisted laser desorption ionization time-of-ﬂight mass spectrometry;
NF-H, heavy neuroﬁlament triplet protein; SDS, sodium dodecyl
sulphate
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doi:10.1016/j.febslet.2006.10.023referred to as nuclear lamina. The lamina proteins, in particular
the lamins, have recently received much attention, as mutations
in several of them cause severe human disease (for recent re-
views, see [1–3]). Like all IF proteins, the nuclear lamins exhibit
a tripartide organization with a central a-helical rod domain, a
relative short non-a-helical amino-terminal domain (‘‘head’’)
and a long non-a-helical carboxy-terminal domain (‘‘tail’’),
which harbors a globular Ig-fold subdomain (reviewed in [4]).
In less complex metazoans such as Caenorhabditis elegans, a
single lamin gene is found, whereas higher vertebrates contain
three lamin genes, LMNA, LMNB1 and LMNB2. According
to their position after one dimensional gel electrophoresis,
the major lamin protein bands as found in rat liver nuclear
envelopes have been termed A, B and C [5], and sequencing
of cloned cDNAs revealed that lamins can be distinguished
into A- and B-type according to amino acid sequence homol-
ogy (reviewed in [6]). Interestingly, some lamins appear in var-
ious splice forms, which is rather uncommon among the more
than 70 cytoplasmic IF gene products [7]. Hence, lamin A and
lamin C are derived from one gene and are identical for their
ﬁrst 566 amino acids [8,9]. For both A- and B-type lamins,
germ cell speciﬁc splice forms exist, e.g. lamin C2 for the A-
type and lamin B3 for the B-type lamin [10]. In addition, lamin
B2 has been described to yield two diﬀerent bands upon gel
electrophoretic separation, and it was speculated that these
two bands represent diﬀerentially phosphorylated lamin B2
species [11]. One of the structural hallmark features of lamins
is the rather short length of their non-a-helical ‘‘head’’
domains which correlates in addition with the absence of an
a-helical pre-coil domain found in many cytoplasmic IF
proteins. Nevertheless, the B-type lamins of C. elegans and
Drosophila melanogaster have heads that come close in length
to that of the glial acid ﬁbrillar protein (GFAP) but are still
considerably shorter than that of cytoplasmic vimentin [4].
We report here that for human lamin B2 the head domain
has not been described in its entire length. We determined that
the human lamin B2 is 20 amino acids longer that previously
reported. By generating antisera against a peptide representing
this potential new amino-terminal segment, we demonstrate
that human lamin B2 is indeed synthesized as a longer version
in human cells. Moreover, also chimpanzee, mouse, rat and
bovine lamin B2 harbor a corresponding sequence preceding
the up to now assumed translational start. Hence, humanblished by Elsevier B.V. All rights reserved.
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helical head domain. In light of the importance of this domain
for lamina assembly [12], it will be important to investigate the
contribution of the additional amino acid element to proper
lamina formation in the future.2. Materials and methods
2.1. Molecular biological and biochemical procedures
The full-length lamin B2 cDNA clone BC006551 (NCBI data bank)
was obtained from the German Resource Center for Genome Research
(RZPD, Berlin, Germany). It was subcloned into the vector pEGFP-
N1 (Clontech, Mountain View, CA, USA) and a pET-24d vector mod-
iﬁed to contain a 6· His motif immediately following the start ATG
using standard techniques. Cultured cells were extracted with 0.2%
NP-40 to yield membranous and cytoskeletal fractions [13]. For the
generation of antisera, chemically synthesized peptides were coupled
to KLH (Peptide Specialty Laboratories, Heidelberg, Germany), and
injected into guinea pigs, one time with complete and three times with
incomplete Freund’s adjuvant, each at four-week intervals. In
addition, guinea pig sera were produced against the peptide stretch
GELTVAQGRVKDLESLFHRSEVEL from coil 1B (amino acids
140–163). Sera were aﬃnity-puriﬁed on columns harboring the coupled
peptide used for immunization. For comparison, the mouse monoclo-
nal antibody X223 was employed [14]. Employing amino-terminal
recombinant fragments [15] and a His-tagged recombinant lamin B2
preparation partially being degraded from the carboxy-terminus, we
localized the epitope of the X223 antibody to coil 1B. The chimpanzee
genomic lamin B2 sequence was found at UCSC Genome Bioinfor-
matic (http://genome.ucsc.edu/) at position 2474051-2474149 on chro-
mosome 19 when searching with the human sequence for lamin B2
(release August 23rd, 2006).2.2. RNA isolation, cDNA synthesis and PCR ampliﬁcation
For the isolation of cellular poly(A) mRNA from MCF7 and HeLa
cells, three (for MCF7) or one (for HeLa) 2.5 cm Petri dishes were ex-
tracted (80% conﬂuency). RNA isolation was performed with the
RNeasy Mini Kit according to the manufacturers’ protocol, including
the on-column DNase step (Qiagen, Hilden, Germany). Strict precau-
tions against contamination were taken and appropriate negative con-
trols were included. cDNAs were synthesized from 2.0 lg of total
RNA by Superscript II RNase H-Reverse Transcriptase (Invitrogen,
Karlsruhe, Germany) using an oligo d(T) primer (Invitrogen, Kar-
lsruhe, Germany). 5.0 ll of the obtained cDNA product each was em-
ployed for the ampliﬁcation with KOD Hot Start DNA Polymerase
(Toyobo, Osaka, Japan). Ampliﬁcation primers for lamin B2 were as
follows: primer 1 (forward) 5 0-GAGGGATCCATGAGCCCGCCG-
AGCCCGGG-3 0; primer 2 (reverse) 5 0-CCCCGGCCATGGCCTCC-
TCCAGCTCCCG-3 0; primer 3 (forward) 5 0-GCCAGTGCCGCT-
GAAGATCG-3 0; and primer 4 (reverse) 5 0-GAGGAATTCGATAT-
AAAAATAGTTTTCAGTGGC-3 0. Ampliﬁed DNA fragments
corresponded to nucleotides 1–1033 (exons 1–7) and 982–1925 (exons
7–12), respectively. PCR products were separated by electrophoresis
on 0.8% agarose gels in the presence of the GeneRuler 1 kb molecu-
lar weight marker (Fermentas, St. Leon-Roth, Germany). For control,
we ampliﬁed a 267 bp fragment from GAPDH. The nucleotide
sequence of the forward primer was 5 0-GTCTTCACCACCATGGA-
GAA-3 0 and the reverse primer was 5 0-ATCCACAGTCTTCTGGG-
TGG-3 0.2.3. SDS-gel electrophoresis
For optimal separation of the lamins A, B and C, 10% polyacryl-
amide gels (20 · 20 cm) were run over night at 8 mA. In the morning,
the current was raised to 40 mA. After the bromphenol blue marker
had moved out of the gel, electrophoresis was continued for another
2–2.5 h. Gel electrophoresis, isoelectric focussing and non-equilibrium
pH gradient electrophoresis were carried out as described [16].
2.4. Mass spectrometry
Proteins from cytoskeletal fractions were separated on 12% poly-
acrylamide gels run for extended times to obtain best separation inthe 60–70 kDa range, and Coomassie-stained bands were excised for
digestion with trypsin. For the mass spectrometric analysis of the
tryptic digests, samples were prepared on anchor chip targets using
a-cyano-4-hydroxycinnamic acid as matrix. Matrix-assisted laser
desorption ionization time-of-ﬂight mass spectrometry (MALDI-
TOF MS) analysis and subsequent database searches were performed
as described [17].2.5. Cell culture and ﬂuorescence microscopy
Cells of lines SW-13 (ATCC: CCL-105), MCF7 (ATCC: HTB-22)
and PLC (ATCC: CRL-8024) as well as mouse NIH 3T3 and calf lens
cells [18] were cultured as described in the corresponding source proto-
col. For cDNA transfection, we employed Fugene 6 according to the
suggestions of the supplier (Roche, Mannheim, Germany). Fluores-
cence and immunoﬂuorescence microscopy were done according to
published procedures [19].3. Results
The NCBI data bank contains numerous new additions of
EST clones coding for human lamin B2. Many of them, e.g.
BC006551, have an additional ATG codon 60 nucleotides up-
stream of the ATG assumed to be the proper initiation codon
for translation. Immediately in front of this new potential start
codon a nonsense codon (TGA) is located in this reading
frame, whereas no nonsense codon was found between both
the new and the oﬃcial ATG codon. Hence, the additional
cDNA sequence would translate into a 20-mer peptide segment
with the sequence (in one-letter-code) MSPPS PGRRR
EQRRP RAAAT. These types of amino acids are commonly
found in IF head domains (Fig. 1). Moreover, the recent geno-
mic sequence of lamin B2 from the chimpanzee, Pan troglo-
dytes, also exhibits 60 nucleotides in front of the previously
assumed AUG translating into a very similar sequence: MIPPS
PGRRR EQRRP RARRT. The three amino acids highlighted
in bold diﬀer from the human sequence. Inspection of the pub-
lished genomic sequences as well as of cDNAs of mouse, rat
and bovine lamin B2 revealed that at a corresponding position
all of them contained an in frame ATG codon indicating that
also their lamin B2 polypeptides may be translated with a
sequence element not considered up to now (Fig. 1). The pub-
lished Xenopus laevis lamin LII (the ortholog of mammalian
lamin B2) has a corresponding though shorter extension too,
and further data bank searches revealed that also two cartila-
ginous ﬁsh sequences contain a corresponding extension,
although again with much less sequence homology compared
to that of coil 1A and the segment immediately preceding it
(Fig. 1). Most notably, this high degree of sequence identity
does not break up with the CdK1-phosphorylation site, SPTR,
which is conserved from man to the fruitﬂy, but is preceded by
a highly conserved tetrapeptide, (A/S)(T/S)PL.
In order to verify that this species-speciﬁc amino-terminal
extension is indeed translated into protein in vivo, we immu-
nized three guinea pigs with the 20-mer peptide representing
this extra sequence of human lamin B2 (highlighted in yellow
in Fig. 1). All sera obtained speciﬁcally recognized recombi-
nant (data not shown) and authentic human lamin B2 from
cytoskeletal preparation of several human cell lines (here
shown for MCF7, HeLa and SW-13 cells; Fig. 2A and B).
Interestingly, all three sera detected a second, minor band at
the position of lamin B1, which was not recognized to the same
extent by the monoclonal antibody X223 originally produced













Fig. 1. Sequence comparison of the amino-terminal non-a-helical ‘‘head’’ domain and part of coil 1A of various vertebrate and invertebrate lamin B2
proteins. Hs, Homo sapiens; Mm, Mus musculus; Rn, Rattus norvegicus: Bt, Bos taurus; Xl, Xenopus laevis; Ol, Oryzias latipes; Hc, Haplochromis
chilotes; Dm, Drosophilamelanogaster; Ce, Caenorhabditis elegans. Blue columns: identical amino acids in all species. Red columns: identical in more
than half of the species; similar amino acids are also colored in red. Green: second, previously ‘‘oﬃcial’’ methionine in the non-a-helical head domain,
which is absent in the invertebrate lamins. The newly identiﬁed amino-terminal ‘‘extension’’ is highlighted in yellow.
Fig. 2. Immunoblot analysis of cytoskeletal fractions of the human
cell lines MCF7, HeLa and SW-13. (A) protein stain, (B) reaction with
the peptide-generated anti-lamin B2 antibodies (serum1) and (C)
reaction with the monoclonal antibody X223. MCF7 (lanes 1), HeLa
(lanes 2) and SW-13 (lanes 3). The upper two panels on the left
indicate, from top to bottom: immunostain of a MCF7 cytoskeletal
fraction with serum 1 (Ser1) and the same blot immunostained with
X223. The bottom left panel is an enlargement of the separation
pattern of the cytoskeletal fraction of MCF7 cells shown in (A), boxed
area. Bold letters on the left indicate the identity of the corresponding
bands as determined using lamin type-speciﬁc immunological reagents;
P1–P4 indicates bands as excised for MALDI-TOF MS analysis. M,
molecular weight of marker proteins, from top to bottom: 212000;
158194; 116351; 97164; 66409 (double amount); 55561.
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lian species (Fig. 2C). Only after prolonged exposure, also the
X223 antibody reacted with this band (Fig. 2, 2D gel panels).
This indicated that the upper band most likely represents a
post-translationally modiﬁed form of lamin B2. The modiﬁca-
tion may lie close to the epitope of the antibody X223, which
has been mapped to coil 1B ([20] and Section 2), and may
therefore obstruct the optimal interaction of the antibody with
its epitope. Another polyclonal antibody, generated in guineapigs against a lamin B2-speciﬁc sequence motif of coil 1B,
yielded a reaction pattern identical to that of the amino-termi-
nal-speciﬁc sera (data not shown). As previously reported, the
upper band probably represents lamin B2 phosphorylated at
multiple sites [11]. Extensive phosphorylation has been demon-
strated to signiﬁcantly reduce the mobility of various proteins
including, for instance, the neuroﬁlament triplet proteins [21]
and high molecular weight microtubule-associated proteins
MAP 1 and 2 [22]. Accordingly, the lower mobility band of
lamin B2 exhibits a more acidic isoelectric point in non-equilib-
rium pH gradient electrophoresis (NEPHGE). The nature of
this modiﬁcation on coil 1B is subject for future investigation.
Immunoﬂuorecence microscopy employing the human cul-
tured cell lines SW-13, MCF7 and PLC revealed that both
the three amino-terminus-speciﬁc sera and X223 yielded iden-
tical staining patterns highlighting the nuclear rim with practi-
cally no staining in the cytoplasm (Fig. 3). No signal was
obtained with the three sera on mouse NIH 3T3 and calf lens
cells indicating they react species-speciﬁc. Moreover, employ-
ing both types of antibodies we did not obtain any hint on dif-
ferential localization of the lower migrating component
compared to the major band migrating in front of lamin B1
both in interphase and in mitotic cells (see Fig. 3, upper pan-
els). Finally, as a cautionary note for biochemical analyses it
should be considered that within the bulk of lamin B1 some
lamin B2, i.e. the ‘‘upper band’’, is comigrating (see Fig. 2, left
lower panel). To further investigate if the lower band
represents a splice form diﬀering from that coded for by the
common EST sequence – similar to the lamin A pre-mRNA,
which is spliced to yield lamin A and the carboxy-terminally
shortened lamin C [8] – we performed RT-PCR on poly(A)
mRNA of human MCF7 and HeLa cells, respectively. Using
two sets of primers, we ampliﬁed the whole mRNA in overlap-
ping fragments of 1033 and 943 bp, respectively (Fig. 4). There
was no indication, however, for the existence of any fragment
of a diﬀering size, especially in the second half covering the tail
region of the protein. Therefore, we conclude that the diﬀerent
mobilities of both proteins during SDS–polyacrylamide gel
electrophoresis are not caused by diﬀerential splicing of a
full-length pre-mRNA. Moreover, to further support these
data, we performed an exhaustive mass spectrometric analysis,
in particular of the lower migrating form (see Fig. 2, P3 in the
lower left panel). We obtained a signiﬁcant coverage of the tail
domain yielding amino acid fragments as predicted by
the cDNA sequence. The identiﬁed fragments cover most of
the non-a-helical tail domain. The fragment nearest to the
Fig. 3. Double immunoﬂuorescence microscopic analysis of human cultured cells from the adrenal cortex carcinoma-derived cell line SW-13
employing (A, B) one of the peptide-generated anti-lamin B2 antibodies (Ser1) and (A
0, B0) the monoclonal antibody X223; (A00, B00), DNA stain
(DAPI). Arrowheads in (A) indicate mitotic cells being in metaphase and telophase, respectively. Bars, 10 lm.
Fig. 4. RT-PCR analysis of transcripts isolated from human cell lines MCF7 and HeLa. (A), ampliﬁcation schedule indicating the expected sizes of
the two fragments as obtained with primer set 1 and primer set 2, respectively. For details see Section 2.2. (B), agarose electrophoresis of PCR
products. M, molecular weight marker; lanes 2, 4: DNA ampliﬁed with the ﬁrst primer set (primers 1 and 2), lanes 3, 5: DNA ampliﬁed with the
second primer set (primers 3 and 4).
6214 J. Schumacher et al. / FEBS Letters 580 (2006) 6211–6216carboxy-terminus ends six amino acids before the cysteine of
the CAAX box. Therefore, we can exclude the use of an addi-
tional carboxy-terminal end segment for this protein (Table 1).
In accordance, comparing numerous EST sequences of theTable 1
Mass spectrometric analysis of tryptic fragments derived from gel-puriﬁed h
aFragments obtained from recombinant lamin B2 are underlined, those gene
rations are shown in bold.NCBI gene bank we did not obtain any cDNA diﬀering in
the translated sequence (data not shown).
In this context it is important to note, however, that the
originally published human lamin B2 sequence contained auman lamin B2
a
rated from gel-puriﬁed lamin B2 of human MCF7 cytoskeletal prepa-
Fig. 5. Forced expression in SW-13 cells of GFP-tagged (A; A 0) full-
length lamin B2 and (B, B
0) lamin B2 missing the ﬁrst 20 amino acids.
(A, B), ﬂuorescence image; (A 0, B 0), DNA stain (DAPI). Bar, 10 lm.
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niﬁcantly from that of other vertebrates [23]. Hence, this se-
quence most probably contains alterations introduced during
the synthesis of the original cDNA by reverse synthetase or
sequencing errors. The introduction of a single nucleotide at
three positions each within a 110 bp segment of their sequence
reconstitutes the very sequence of the EST clones released by
the NCBI. Our mass spectrometric data furthermore conﬁrm
the accuracy of the EST sequences obtained for this region.
Finally, in order to evaluate if the newly identiﬁed sequence
motif of lamin B2 leads to any alteration in the nucleoskeleton
when ectopically expressed, we transfected SW-13 cells with
the GFP-tagged version of the full-length lamin B2 clone. In-
deed, the full-length lamin B2 incorporated entirely into the
nuclear lamina without any sign for intra-nuclear or other kind
of non-envelope localization in most of the cells (Fig. 5A and
A 0). In contrast, the shorter version exhibited a tendency to
cause mild lobulation at higher expression levels indicating
the extra sequence element may play a role in the proper inte-
gration of lamin B2 into the lamina (Fig. 5B and B
0).
4. Discussion
We have demonstrated employing protein-chemical methods
that human lamin B2 contains 20 amino acids more at its
amino-terminus than previously reported. Hence, the total
sum of amino acids in the non-a-helical head domain com-
prises 45 for the human protein. Moreover, on close inspection
of the chimpanzee lamin B2 gene sequence as well as that of
mouse, rat and bovine gene and cDNA sequences, we notedthat for these mammalian lamin B2 molecules the non-a-helical
head domain is also longer than previously anticipated [24]. In
addition, each the human, mouse and bovine sequence harbor
an additional potential CdK1 recognition site in this segment.
According to the published sequences, the human lamin B2
has 620 amino acids in the fully translated form, whereas lamin
B1 comprises 586 amino acids, translating into theoretical
molecular weights of 69948 and 66408, respectively, and hence
both should migrate very close or even within one band.
Nevertheless, the faster migrating lamin B2 appears to be a
full-length version of the protein, since in MALDI-TOF MS
experiments we detected the last tryptic fragment preceding
the CAAX-box, i.e. we obtained sequence coverage down to
ﬁve amino acids before the carboxy-terminal cysteine, and in
addition, our new, amino-terminus speciﬁc antibodies recog-
nizes both the upper and the lower band. Hence, these results
make it very unlikely that a fragment is spliced out internally.
Moreover, the RT-PCR experiments did not give any hint for
a major diﬀerentially spliced form. Therefore, one of the two
lamin B2 bands represents possibly a post-translationally mod-
iﬁed form, where the modiﬁcation interferes with the expected
migration on SDS–polyacrylamide gels. Alternatively, the fas-
ter migrating form could be modiﬁed such that its migration is
enhanced. Such relatively small changes, i.e. estimated 5 kDa,
may easily be caused by post-translational modiﬁcations. In
the extreme case, the mass of the IF protein heavy neuroﬁla-
ment triplet protein (NF-H) has been estimated to amount
to 220 kDa by SDS–polyacrylamide gel electrophoresis
whereas cloning revealed its sequence translates only into a
molecule with a mass of 112 kDa [21,25]. Both the high con-
tent of glutamic acid and the extensive phosphorylation of
the up to 50 KSP sites in the non-a-helical tail domain have
been speculated to suppress the binding of appropriate
amounts of SDS to NF-H and be the cause for this unusual
behavior. Interestingly, in an early report on the molecular
characterization of lamin B2 from diﬀerent species, a second
isoelectric variant has been described for rat [26]. Also in this
case the minor, upper band was more acidic. In contrast, a cor-
responding variant was not observed in chicken samples.
Moreover, the migration properties of lamin B1 and B2 diﬀered
in the two species, the chicken lamin B1 migrating faster than
B2, which is the opposite in rat and man.
Surprisingly little work has been conducted on post-transla-
tional modiﬁcations of lamins. Therefore, more work is needed
to characterize these and potential other modiﬁcations, which
may not only modify the biophysical and biochemical proper-
ties of these proteins but also their functions. It may be of
interest to note that in man lamin A/C carries multiple muta-
tions leading to severe, complex diseases such as cardiomyo-
pathy and premature aging [1,2,27], and recently also a
mutation in lamin B2 was demonstrated to cause disease [28].
The latter paper also reports the more complex exon structure
of lamin B2, although it is not commented on the additional
start codon. Last but not least, alternative promotor usage
[29] may lead to an even longer transcript, i.e. give rise to an
additional amino-terminal part with the 20 amino acid seg-
ment detected by us lying downstream of it. Such a scenario
could explain the less abundant, lower mobility band, which
is positive both for the Ser1 and X223. More information on
the properties of the lamin B2 gene locus is surely needed,
and this will require further intensive characterization of this
rather complex IF gene [30].
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